1. Home
  2. NATH vs AURA Comparison

NATH vs AURA Comparison

Compare NATH & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$100.59

Market Cap

411.8M

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.71

Market Cap

333.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATH
AURA
Founded
1916
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.8M
333.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NATH
AURA
Price
$100.59
$5.71
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.20
AVG Volume (30 Days)
40.6K
200.1K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
1.99%
N/A
EPS Growth
22.29
9.33
EPS
4.17
N/A
Revenue
$104,201,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.12
N/A
Revenue Growth
7.81
N/A
52 Week Low
$88.00
$4.73
52 Week High
$118.32
$7.73

Technical Indicators

Market Signals
Indicator
NATH
AURA
Relative Strength Index (RSI) 56.02 49.96
Support Level $100.25 $5.08
Resistance Level $101.86 $6.12
Average True Range (ATR) 0.46 0.42
MACD -0.23 0.05
Stochastic Oscillator 25.22 57.53

Price Performance

Historical Comparison
NATH
AURA

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: